A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

Mitsukuni Suenaga,1 Nobuyuki Mizunuma,1 Satoshi Matsusaka,1 Eiji Shinozaki,1 Masato Ozaka,1 Mariko Ogura,1 Keisho Chin,1 Toshiharu Yamaguchi2 1Department of Gastroenterology, 2Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Res...

Full description

Bibliographic Details
Main Authors: Suenaga M, Mizunuma N, Matsusaka S, Shinozaki E, Ozaka M, Ogura M, Chin K, Yamaguchi T
Format: Article
Language:English
Published: Dove Medical Press 2015-03-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/a-phase-iii-study-of-biweekly-capecitabine-and-irinotecan-plus-bevaciz-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/a-phase-iii-study-of-biweekly-capecitabine-and-irinotecan-plus-bevaciz-peer-reviewed-article-DDDT

Similar Items